PSUSA/00000444/202512
PSUSA/00000444/202512
PSUSA/00000444/202512
Draft reflection paper on particulars for safety signals for (traditional) herbal medicinal products
Executive Director Emer Cooke's speech at the European Parliament's Committee on Public Health
Quality Working Party
Concept paper on the revision of the guidelines on Good Manufacturing Practice for medicinal products - Annex 15 - Qualification and validation - Corrigendum
Human medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Date of authorisation: 31/07/2020, Revision: 11, Status: Authorised
EU Innovation Network (EU-IN)
Severe cutaneous adverse reactions - standard template wording for product information
Scientific advice and protocol assistance adopted during the CHMP meeting 22-25 June 2026
List of substances and products subject to worksharing for signal management